JPRN-jRCT2080220609未知3 期
Clinical study of SM-11355 in patients with hepatocellular carcinoma (Phase III Study)
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients histologically and/or clinically diagnosed with hepatocellular carcinoma, with a measurable lesion, patients with tumor stain in contrast enhanced CT imaging, patients for whom hepatectomy, PEIT, PMCT, or RFA is not indicated
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Study of LY2157299 in Patients With Liver CancerCarcinoma, hepatocellularMedDRA version: 20.0Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentSystem Organ Class: 100000004864EUCTR2010-022338-10-DEEli Lilly and Company204
未知
2 期
A Phase II study of TSU-68 in patient with hepatocellular carcinomaHepatocellular CarcinomaJPRN-jRCT2080221054Taiho Pharmaceutical Co., Ltd.100
未知
1 期
Clinical Pharmacology study for AS-3201 in hepatic impairment subjectsJPRN-jRCT2080222664Sumitomo Dainippon Pharma Co., Ltd.18
未知
2 期
Phase IIb Study of S-555739 in Patients with Seasonal Allergic RhinitisSeasonal allergic rhinitisJPRN-jRCT2080221656SHIONOGI & CO., LTD.
未知
2 期
Phase IIa Study of S-555739 in Patients with Seasonal Allergic RhinitisSeasonal allergic rhinitisJPRN-jRCT2080221324SHIONOGI & CO., LTD.